` VLA (Valneva SE) vs DAX Index Comparison - Alpha Spread

VLA
vs
DAX Index

Over the past 12 months, VLA has underperformed DAX Index, delivering a return of -33% compared to the DAX Index's 29% growth.

Stocks Performance
VLA vs DAX Index

Loading
VLA
DAX Index
Add Stock
www.alphaspread.com

Performance Gap
VLA vs DAX Index

Loading
VLA
DAX Index
Difference
www.alphaspread.com

Performance By Year
VLA vs DAX Index

Loading
VLA
DAX Index
Add Stock

Competitors Performance
Valneva SE vs Peers

DAX Index
VLA
ABBV
AMGN
GILD
VRTX
Add Stock

Valneva SE
Glance View

Market Cap
456.7m EUR
Industry
Biotechnology

Valneva SE is a biotech company. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 722 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

VLA Intrinsic Value
2.802 EUR
Fairly Valued
Intrinsic Value
Price
Back to Top